Skip to main content
SpringerLink
Log in

Lifestyle Medicine and Chronic Pulmonary Disease

  • Chapter
  • First Online:
Book cover Lifestyle Medicine

  • 2045 Accesses

Abstract

Lifestyle medicine plays an important role in the prevention and management of chronic pulmonary disease. Presently, medical treatment options available for chronic pulmonary diseases can improve respiratory symptoms and quality of life, but scientific evidence shows that attention to lifestyle medicine issues can further enhance the benefit of these therapies. This chapter will focus on four specific chronic pulmonary diseases: cystic fibrosis, chronic obstructive pulmonary disease, asthma, and interstitial lung disease. Relevant lifestyle interventions that can significantly improve quality of life in patients with these diseases are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ADL:

Activities of daily living

BMD:

Bone mineral density

BMI:

Body mass index

CF:

Cystic fibrosis

CFA:

Coefficient of fat absorption

CFTR:

Cystic fibrosis transmembrane conductance regulator

COPD:

Chronic obstructive pulmonary disease

DASH:

Dietary approaches to stop hypertension

DIOS:

Distal intestinal obstruction syndrome

DIP:

Desquamative interstitial pneumonia

EELV:

End-expiratory lung volume

EPI:

Exocrine pancreatic insufficiency

ERV:

Expiratory reserve volume

FE1:

Fecal pancreatic elastase-1

FEV1:

Forced expiratory volume at 1 s

FFM:

Fat-free mass

FVC:

Forced vital capacity

GI:

Gastrointestinal

ILD:

Interstitial lung disease

IM:

Intramuscular

IPF:

Idiopathic pulmonary fibrosis

MMA:

Methylmalonic acid

NAC:

N-acetyl cysteine

NREM:

Non-rapid eye movement

OSA:

Obstructive sleep apnea

PERT:

Pancreatic enzyme replacement therapy

PLCH:

Pulmonary Langerhans’ cell histiocytosis

PMN:

Polymorphonuclear leukocytes

PN:

Parenteral nutrition

ppd:

Pack per day

RBILD:

Respiratory bronchiolitis-associated interstitial lung disease

REE:

Resting energy expenditure

ROS:

Reactive oxygen species

TST:

Total sleep time

References

  1. Cahill K, et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;5:Cd009329.

    Google Scholar 

  2. O’sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373(9678):1891–904.

    Article  PubMed  Google Scholar 

  3. Somaraju UR, Solis-Moya A. Pancreatic enzyme replacement therapy for people with cystic fibrosis. Cochrane Database Syst Rev. 2014;10:Cd008227.

    Google Scholar 

  4. Stallings VA, et al. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc. 2008;108(5):832–9.

    Article  PubMed  Google Scholar 

  5. Sinaasappel M, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros. 2002;1(2):51–75.

    Article  CAS  PubMed  Google Scholar 

  6. Conway SP, Morton A, Wolfe S. Enteral tube feeding for cystic fibrosis. Cochrane Database Syst Rev, 2008;2:Cd001198.

    Google Scholar 

  7. Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol. 2011;4:55–73.

    PubMed  PubMed Central  Google Scholar 

  8. Bruno MJ, et al. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment. Am J Gastroenterol. 1995;90(9):1383–93.

    CAS  PubMed  Google Scholar 

  9. Corey M, et al. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583–91.

    Article  CAS  PubMed  Google Scholar 

  10. Donovan DS Jr., et al. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1892–9.

    Article  PubMed  Google Scholar 

  11. Ferguson JH, Chang AB. Vitamin D supplementation for cystic fibrosis. Cochrane Database Syst Rev. 2012;4:Cd007298.

    Google Scholar 

  12. Stalvey MS, Clines GA. Cystic fibrosis-related bone disease: insights into a growing problem. Curr Opin Endocrinol Diabetes Obes. 2013;20(6):547–52.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Tangpricha V, et al. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metab. 2012;97(4):1082–93.

    Article  CAS  PubMed  Google Scholar 

  14. Smyth AR, et al. European Cystic Fibrosis Society Standards of Care: best practice guidelines. J Cyst Fibros. 2014;13(Suppl 1): S23–42.

    Article  PubMed  Google Scholar 

  15. Gaskin KJ. Nutritional care in children with cystic fibrosis: are our patients becoming better? Eur J Clin Nutr. 2013;67(5):558–64.

    Article  CAS  PubMed  Google Scholar 

  16. Gueant JL, et al. Malabsorption of vitamin B12 in pancreatic insufficiency of the adult and of the child. Pancreas. 1990;5(5):559–67.

    Article  CAS  PubMed  Google Scholar 

  17. Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149–60.

    Article  CAS  PubMed  Google Scholar 

  18. Ciofu O, Lykkesfeldt J. Antioxidant supplementation for lung disease in cystic fibrosis. Cochrane Database Syst Rev. 2014;8:Cd007020.

    Google Scholar 

  19. Chinuck R, et al. Appetite stimulants for people with cystic fibrosis. Cochrane Database Syst Rev. 2014;7:Cd008190.

    Google Scholar 

  20. Eubanks V, et al. Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis. J Pediatr. 2002;140(4):439–44.

    Article  CAS  PubMed  Google Scholar 

  21. Homnick DN, Marks JH, Rubin BK. The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis. J Aerosol Med. 2007;20(1):45–9.

    Article  CAS  PubMed  Google Scholar 

  22. Marchand V, et al. Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2000;31(3):264–9.

    Article  CAS  PubMed  Google Scholar 

  23. Schneiderman-Walker J, et al. A randomized controlled trial of a 3-year home exercise program in cystic fibrosis. J Pediatr. 2000;136(3):304–10.

    Article  CAS  PubMed  Google Scholar 

  24. Fonseca Wald EL, et al. Dietary fibre and fatty acids in chronic obstructive pulmonary disease risk and progression: a systematic review. Respirology. 2014;19(2):176–84.

    Article  PubMed  Google Scholar 

  25. Vestbo J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.

    Article  CAS  PubMed  Google Scholar 

  26. Landbo C, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–61.

    Article  CAS  PubMed  Google Scholar 

  27. Ora J, et al. Effect of obesity on respiratory mechanics during rest and exercise in COPD. J Appl Physiol (1985). 2011;111(1):10–9.

    Article  Google Scholar 

  28. Schols AM, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J. 2014;44(6):1504–20.

    Article  PubMed  Google Scholar 

  29. O’Donnell DE, Ciavaglia CE, Neder JA. When obesity and chronic obstructive pulmonary disease collide. Physiological and clinical consequences. Ann Am Thorac Soc. 2014;11(4):635–44.

    Article  PubMed  Google Scholar 

  30. Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1385–95.

    Article  CAS  PubMed  Google Scholar 

  31. Schols AM. Nutrition as a metabolic modulator in COPD. Chest. 2013;144(4):1340–5.

    Article  CAS  PubMed  Google Scholar 

  32. Ezzell L, Jensen GL. Malnutrition in chronic obstructive pulmonary disease. Am J Clin Nutr. 2000;72(6):1415–6.

    CAS  PubMed  Google Scholar 

  33. Collins PF, Elia M, Stratton RJ. Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology. 2013;18(4):616–29.

    Article  PubMed  Google Scholar 

  34. Britton JR, et al. Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med. 1995;151(5):1383–7.

    Article  CAS  PubMed  Google Scholar 

  35. Chen R, et al. Association of dietary antioxidants and waist circumference with pulmonary function and airway obstruction. Am J Epidemiol. 2001;153(2):157–63.

    Article  CAS  PubMed  Google Scholar 

  36. Chuwers P, et al. The protective effect of beta-carotene and retinol on ventilatory function in an asbestos-exposed cohort. Am J Respir Crit Care Med. 1997;155(3):1066–71.

    Article  CAS  PubMed  Google Scholar 

  37. Ford ES, et al. Associations between antioxidants and all-cause mortality among US adults with obstructive lung function. Br J Nutr. 2014;112(10):1662–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Grievink L, et al. Dietary intake of antioxidant (pro)-vitamins, respiratory symptoms and pulmonary function: the MORGEN study. Thorax. 1998;53(3):166–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Schunemann HJ, et al. Lung function in relation to intake of carotenoids and other antioxidant vitamins in a population-based study. Am J Epidemiol. 2002;155(5):463–71.

    Article  PubMed  Google Scholar 

  40. Kan H, et al. Dietary fiber, lung function, and chronic obstructive pulmonary disease in the atherosclerosis risk in communities study. Am J Epidemiol. 2008;167(5):570–8.

    Article  PubMed  Google Scholar 

  41. Varraso R, Willett WC, Camargo CA Jr. Prospective study of dietary fiber and risk of chronic obstructive pulmonary disease among US women and men. Am J Epidemiol. 2010;171(7):776–84.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Zuo L, et al. Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments. Am J Physiol Lung Cell Mol Physiol. 2014;307(3):L205–18.

    Article  CAS  PubMed  Google Scholar 

  43. Willemse BW, et al. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J. 2005;26(5):835–45.

    Article  CAS  PubMed  Google Scholar 

  44. Simmons MS, et al. Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study. Eur Respir J. 2005;25(6):1011–7.

    Article  CAS  PubMed  Google Scholar 

  45. Ind PW. COPD disease progression and airway inflammation: uncoupled by smoking cessation. Eur Respir J. 2005;26(5):764–6.

    Article  CAS  PubMed  Google Scholar 

  46. Waschki B, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–42.

    Article  CAS  PubMed  Google Scholar 

  47. Spruit MA, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–e64.

    Article  PubMed  Google Scholar 

  48. Borges RC, Carvalho CR. Impact of resistance training in chronic obstructive pulmonary disease patients during periods of acute exacerbation. Arch Phys Med Rehabil. 2014;95(9):1638–45.

    Article  PubMed  Google Scholar 

  49. O’Donnell DE, Gebke KB. Examining the role of activity, exercise, and pharmacology in mild COPD. Postgrad Med. 2014;126(5):135–45.

    Article  PubMed  Google Scholar 

  50. Yohannes AM, Alexopoulos GS. Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes. Drugs Aging. 2014;31(7):483–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Blakemore A, et al. Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2014;9:501–12.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Maurer J, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl):43 s–56 s.

    Google Scholar 

  53. Whiteford HA, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575–86.

    Article  PubMed  Google Scholar 

  54. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry. 2000;15(12):1090–6.

    Article  CAS  PubMed  Google Scholar 

  55. Vincent EE, Singh SJ. Review article: addressing the sexual health of patients with COPD: the needs of the patient and implications for health care professionals. Chron Respir Dis. 2007;4(2):111–5.

    Article  CAS  PubMed  Google Scholar 

  56. Fletcher EC, Martin RJ. Sexual dysfunction and erectile impotence in chronic obstructive pulmonary disease. Chest. 1982;81(4):413–21.

    Article  CAS  PubMed  Google Scholar 

  57. Karadag F, et al. Correlates of erectile dysfunction in moderate-to-severe chronic obstructive pulmonary disease patients. Respirology. 2007;12(2):248–53.

    Article  PubMed  Google Scholar 

  58. Koseoglu N, et al. Erectile dysfunction prevalence and sexual function status in patients with chronic obstructive pulmonary disease. J Urol. 2005;174(1):249–52; discussion 252.

    Article  CAS  PubMed  Google Scholar 

  59. Collins EG, et al. Sexual dysfunction in men with COPD: impact on quality of life and survival. Lung. 2012;190(5):545–56.

    Article  PubMed  Google Scholar 

  60. Schonhofer B, et al. Sexuality in patients with noninvasive mechanical ventilation due to chronic respiratory failure. Am J Respir Crit Care Med. 2001;164(9):1612–7.

    Article  CAS  PubMed  Google Scholar 

  61. Sanders MH, et al. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med. 2003;167(1):7–14.

    Article  PubMed  Google Scholar 

  62. Tarrega J, et al. Predicting nocturnal hypoventilation in hypercapnic chronic obstructive pulmonary disease patients undergoing long-term oxygen therapy. Respiration. 2011;82(1):4–9.

    Article  CAS  PubMed  Google Scholar 

  63. O’Donoghue FJ, et al. Sleep hypoventilation in hypercapnic chronic obstructive pulmonary disease: prevalence and associated factors. Eur Respir J. 2003;21(6):977–84.

    Article  PubMed  Google Scholar 

  64. Holmedahl NH, et al. Sleep hypoventilation and daytime hypercapnia in stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:265–75.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Ma J, et al. DASH for asthma: a pilot study of the DASH diet in not-well-controlled adult asthma. Contemp Clin Trials. 2013;35(2):55–67.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Lv N, Xiao L, Ma J. Dietary pattern and asthma: a systematic review and meta-analysis. J Asthma Allergy. 2014;7:105–21.

    PubMed  PubMed Central  Google Scholar 

  67. Masoli M, et al. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–78.

    Article  PubMed  Google Scholar 

  68. Nurmatov U, Devereux G, Sheikh A. Nutrients and foods for the primary prevention of asthma and allergy: systematic review and meta-analysis. J Allergy Clin Immunol. 2011;127(3):724–33.e1–30.

    Article  PubMed  Google Scholar 

  69. Lange NE, et al. Maternal dietary pattern during pregnancy is not associated with recurrent wheeze in children. J Allergy Clin Immunol. 2010;126(2):250–5, 255.e1–4.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Martindale S, et al. Antioxidant intake in pregnancy in relation to wheeze and eczema in the first two years of life. Am J Respir Crit Care Med. 2005;171(2):121–8.

    Article  PubMed  Google Scholar 

  71. Litonjua AA, et al. Maternal antioxidant intake in pregnancy and wheezing illnesses in children at 2 y of age. Am J Clin Nutr. 2006;84(4):903–11.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Devereux G, et al. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am J Respir Crit Care Med. 2006;174(5):499–507.

    Article  CAS  PubMed  Google Scholar 

  73. Miyake Y, et al. Consumption of vegetables, fruit, and antioxidants during pregnancy and wheeze and eczema in infants. Allergy. 2010;65(6):758–65.

    Article  CAS  PubMed  Google Scholar 

  74. Miyake Y, et al. Maternal fat consumption during pregnancy and risk of wheeze and eczema in Japanese infants aged 16–24 months: the Osaka Maternal and Child Health Study. Thorax. 2009;64(9):815–21.

    Article  CAS  PubMed  Google Scholar 

  75. Camargo CA Jr, et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr. 2007;85(3):788–95.

    CAS  PubMed  PubMed Central  Google Scholar 

  76. Devereux G, et al. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr. 2007;85(3):853–9.

    CAS  PubMed  Google Scholar 

  77. Nwaru BI, et al. An exploratory study of the associations between maternal iron status in pregnancy and childhood wheeze and atopy. Br J Nutr. 2014;112(12):2018–27.

    Article  CAS  PubMed  Google Scholar 

  78. Moreno-Macias H, Romieu I. Effects of antioxidant supplements and nutrients on patients with asthma and allergies. J Allergy Clin Immunol. 2014;133(5):1237–44; quiz 1245.

    Article  CAS  PubMed  Google Scholar 

  79. Bunyavanich S, et al. Peanut, milk, and wheat intake during pregnancy is associated with reduced allergy and asthma in children. J Allergy Clin Immunol. 2014;133(5):1373–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Grande AJ, et al. Water-based exercise for adults with asthma. Cochrane Database Syst Rev. 2014;7:Cd010456.

    Google Scholar 

  81. Carson KV, et al. Physical training for asthma. Cochrane Database Syst Rev. 2013;9:Cd001116.

    Google Scholar 

  82. Avallone KM, McLeish AC. Asthma and aerobic exercise: a review of the empirical literature. J Asthma. 2013;50(2):109–16.

    Article  PubMed  Google Scholar 

  83. Pacheco DR, et al. Exercise-related quality of life in subjects with asthma: a systematic review. J Asthma. 2012;49(5):487–95.

    Article  PubMed  Google Scholar 

  84. Malkia E, Impivaara O. Intensity of physical activity and respiratory function in subjects with and without bronchial asthma. Scand J Med Sci Sports. 1998;8(1):27–32.

    Article  CAS  PubMed  Google Scholar 

  85. Sideleva O, et al. Obesity and asthma: an inflammatory disease of adipose tissue not the airway. Am J Respir Crit Care Med. 2012;186(7):598–605.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Lange P, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339(17):1194–200.

    Article  CAS  PubMed  Google Scholar 

  87. Pietinalho A, Pelkonen A, Rytila P. Linkage between smoking and asthma. Allergy. 2009;64(12):1722–7.

    Article  CAS  PubMed  Google Scholar 

  88. Gilliland FD, et al. Regular smoking and asthma incidence in adolescents. Am J Respir Crit Care Med. 2006;174(10):1094–100.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Baumgartner KB, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997;155(1):242–8.

    Article  CAS  PubMed  Google Scholar 

  90. Ryu JH, et al. Smoking-related interstitial lung diseases: a concise review. Eur Respir J. 2001;17(1):122–32.

    Article  CAS  PubMed  Google Scholar 

  91. Baumgartner KB, et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. Am J Epidemiol. 2000;152(4):307–15.

    Article  CAS  PubMed  Google Scholar 

  92. Vassallo R. Diffuse lung diseases in cigarette smokers. Semin Respir Crit Care Med. 2012;33(5):533–42.

    Article  PubMed  Google Scholar 

  93. Vassallo R, Ryu JH. Smoking-related interstitial lung diseases. Clin Chest Med. 2012;33(1):165–78.

    Article  PubMed  Google Scholar 

  94. du Bois RM, et al. 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2014;43(5):1421–9.

    Article  PubMed  Google Scholar 

  95. Vainshelboim B, et al. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis. Lung. 2015;193(3):345–54. doi:10.1007/s00408-015-9703-0. Epub 2015 March 3.

    Google Scholar 

  96. Dowman L, et al. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2014;10:Cd006322.

    Google Scholar 

  97. Holland AE, et al. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008;63(6):549–54.

    Article  CAS  PubMed  Google Scholar 

  98. Nishiyama O, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13(3):394–9.

    Article  PubMed  Google Scholar 

  99. Lancaster LH, et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest. 2009;136(3):772–8.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Perez-Padilla R, et al. Breathing during sleep in patients with interstitial lung disease. Am Rev Respir Dis. 1985;132(2):224–9.

    CAS  PubMed  Google Scholar 

  101. Bye PT, et al. Studies of oxygenation during sleep in patients with interstitial lung disease. Am Rev Respir Dis. 1984;129(1):27–32.

    CAS  PubMed  Google Scholar 

  102. Won CH, Kryger M. Sleep in patients with restrictive lung disease. Clin Chest Med. 2014;35(3):505–12.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Glen B. Chun MD

  2. Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1232, 10029, New York, NY, USA

    Charles A. Powell MD

Authors
  1. Glen B. Chun MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles A. Powell MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles A. Powell MD .

Editor information

Editors and Affiliations

  1. New York, USA

    Jeffrey I. Mechanick MD

  2. Chicago, USA

    Robert F. Kushner MD

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Chun, G., Powell, C. (2016). Lifestyle Medicine and Chronic Pulmonary Disease. In: Mechanick, J., Kushner, R. (eds) Lifestyle Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-24687-1_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-24687-1_31

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-24685-7

  • Online ISBN: 978-3-319-24687-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation